Skip to main content
SpringerLink
Log in

Supersensitivity of GABA-A receptors in hepatic encephalopathy

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

During the past decade a new approach to pathogenetic, studies of hepatic encephalopathy has been undertaken to identify the neurochemical alterations which characterize the syndrome. Using animal models of hepatic encephalopathy electrophysiological, behavioral, pharmacological and biochem evidence were provided of an increased functional activity of the GABA-A receptors, including the Benzodiazepine site. These demonstrations seem to explain the increased sensitivity of patients with acute or chronic liver disease to sedative administration. The described increased tone of the GABAergic receptor complex seems to play a key role in the generalized depression of the central nervous system which characterizes hepatic encephalopathy, but other factors seem to contribute to the neuronal derangement present in this syndrome leading to an imbalance between inhibitory and excitatory receptor systems in the brain. Based on these findings a new symptomatic treatment with antibenzodazepine compounds which seem temporarely to counteract the symptoms of hepatic encephalopathy, was introduced.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hoyumpa, A.M., and Schenker, S. 1982. Perspective in hepatic encephalopathy. J. Lab. Clin. Invest. 100:477–487.

    Google Scholar 

  2. Adams, R.D., and Foley, J.M. 1953. The neurological disorders associated with liver disease. Annu. Rev. Nerv. Ment. Dis. Proc. 32:198–215.

    Google Scholar 

  3. Diemer, N.H. 1978. Glial and neuronal changes in experimental hepatic encephalopathy. A quantitative morphological investigation. Acta Neurol. Scand. 58 (suppl 71):1–143.

    PubMed  Google Scholar 

  4. Victor, M., Adams, R., and Cole, M. 1965., The acquired (non-Wilsonian) type of chronic hepatocellular degeneration. Medicine. 44:345–396.

    PubMed  Google Scholar 

  5. Martinez, A. 1968. Electromicroscopy in human hepatic encephalopathy. Acta Neurpatol. 11:82–86.

    Google Scholar 

  6. Baraldi, M., Della Giustina, E., and Botticelli, A.R. 1986. Evidence for degenerative changes in neurons in experimental hepatic encephalopathy. Falk Symposium No. 44, 240.

    Google Scholar 

  7. Tubbs, H., Parker, J.D., Murray-Lyon, L.M., and Williams, R. 1977. Cortical and optic atrophy following fulminant hepatic failure. Med. Chir. Dig. 6:75–77.

    PubMed  Google Scholar 

  8. Toda, C., Chiba, T., Matsuda, Y., et al., 1983. A case of brain atrophy after fulminant hepatic failure. Am. J. Gastroenterol. 78:446–447.

    PubMed  Google Scholar 

  9. Zeneroli, M.L., Cioni, G., Vezzelli, C., et al. 1987. Prevalence of brain atrophy in liver cirrhosis patients with chronic encephalopathy: evaluation by computed tomography. J Hepatol. 4:283–292.

    PubMed  Google Scholar 

  10. Bernthal, P., Hays, A., Tarter, R.E., et al. 1987. Cerebral CT scan abnormalities in cholestatic and hepatocellular disease and their relationship to neuropsychologic test performance. Hepatology 7:107–114.

    PubMed  Google Scholar 

  11. Zieve, L. 1981. The mechanism of hepatic coma. Hepatology 1:360–365.

    PubMed  Google Scholar 

  12. James, J.H., Ziparo, V., Jeppson, B., and Fischer, J.E. 1979. Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy. Lancet 2:772–775.

    PubMed  Google Scholar 

  13. Schafer, D.F., and Jones, A.E. 1982. Hepatic encephalopathy and the gamma-aminobutyric acid neurotransmitter system. Lancet 1:18–20.

    PubMed  Google Scholar 

  14. Ferenci, P., Ebner, J., Zimmermann, C., et al. 1988. Overestimation of serum concentrations of gamma-aminobutyric acid in patients with hepatic encephalopathy by the gamma-aminobutyric acid-radioreceptor assay. Hepatology 8:69–72.

    PubMed  Google Scholar 

  15. Mullen, K.D., Martin, J.V., Mendelson, W.B., et al. 1988. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy? Lancet 1:457–459.

    PubMed  Google Scholar 

  16. Olasmaa, M., Guidotti, A., Costa, E., et al., 1989. Endogenous benzodiazepines in hepatic encephalopathy. Lancet 1:491–492.

    PubMed  Google Scholar 

  17. Zeneroli, M.L., Penne, A., Parrinello, G., et al., 1981. Comparative evaluation of visual evoked potentials in experimental hepatic encephalopathy and in pharmacologically induced coma-like state in rat. Life Sci. 28:1507–1515.

    PubMed  Google Scholar 

  18. Zeneroli, M.L., Baraldi, M., Pinelli, G., et al., 1984. Assessment of hepatic encephalopathy in experimental animals. Pages 94–106,in Kleinberger, G., Ferenci, P., Rieder, P., and Thaler, H. (eds), Advances in hepatic encephalopathy and urea cycle diseases, Karger, Basel.

    Google Scholar 

  19. Baraldi, M., Zeneroli, M.L.., Ventura, E., et al., 1984. Portal-systemic encephalopathy in dogs: Changes in brain GABA receptors and neurochemical correlates. Pages 16–19,in Kleinberger, G., Ferenci, P., Rieder, P., Thaler, H., (eds.), Advances in hepatic encephalopathy and urea cycle diseases, Kargel, Basel.

    Google Scholar 

  20. Baraldi, M., Zeneroli, M.L., Ricci, P., et al., 1982. Down regulation of striatal dopamine receptors in experimental hepatic encephalopathy. Life Sci. 32:1417–1425.

    Google Scholar 

  21. Zeneroli, M.L., Ventura, E., Baraldi, M., et al., 1982. Visual evoked potentials in encephalopathy induced by galactosamine, ammonia, dimethyldisulfide and octanoic acid. Hepatology 2:532–538.

    PubMed  Google Scholar 

  22. Zeneroli, M.L., Ventura, E., Pinelli, G., et al. 1985. Opiate receptors and beta-endorphin levels in brain areas of dogs with portal-systemic encephalopathy. J. Hepatol. 1:619–627.

    PubMed  Google Scholar 

  23. Baraldi, M., Zeneroli, M.L. 1982. Experimental hepatic encephalopathy: changes in the binding of gamma-aminobutyric acid. Science 216:427–429.

    PubMed  Google Scholar 

  24. Baraldi, M., and Zeneroli, M.L. 1984. Experimental hepatic encephalopathy: a model to study a distinct high-affinity GABA receptors. Pages 349–356,in Hanin, H., (ed), Dynamics of neurotransmitter function, Raven Press, New York

    Google Scholar 

  25. Guidotti, A., Baraldi, M., and Costa, E. 1979. 1,4-Benzodiazepines and gamma-aminobutyric acid: pharmacological and biochemical correlates. Pharmacology 19:267–277.

    PubMed  Google Scholar 

  26. Baraldi, M., Guidotti, A., Schwartz, J.P., Costa, E. 1979. GABA receptors in clonal cell lines: a model for study of benzodiazepine action at molecular level. Science 205:821–823.

    PubMed  Google Scholar 

  27. Schofield, P.R., Darlison, M.G., Fujita, N., et al. 1987. Sequence and functional expresion of the GABA-A receptor shows a ligand gated receptor sugar-family. Nature 328:221–227.

    PubMed  Google Scholar 

  28. Zeneroli, M.L., Iuliano, E., Racagni, C., and Baraldi, M. 1982. Metabolism of gamma-aminobutyric acid and brain uptake in galactosamine induced hepatic encephalopathy. J. Neurochem. 33:1219–1222.

    Google Scholar 

  29. Waddington, J.I., and Cross, A.J. 1978. Denervation supersensitivy in the striato-nigral GABA pathway. Nature 276:618–620.

    PubMed  Google Scholar 

  30. Gale, K., and Iadarola, M.J. 1980. GABAergic denervation of rat substantia nigra: functional and pharmacological properties. Brain Res. 183:217–223.

    PubMed  Google Scholar 

  31. Baraldi, M., Massotti, M., and Zeneroli, M.L. 1988. Characterization of GABA receptors solubilized from brain membranes of normal rat and in mild and severe stages of galactosamine-induced hepatic encephalopathy. Pages 238–242.in Soeters, P.B., Wilson, J.H.P., Meijer, A.J., and Holm, E. (eds), Advances in ammonia metabolism and hepatic encephalopathy. Excerpta Medica, Amsterdam.

    Google Scholar 

  32. Zeneroli, M.L., and Baraldi, M. 1988. Increased functional activity of the GABA-benzodiazepine receptor unit in a rat model of hepatic encephalopathy. Hepatology 8:1388.

    Google Scholar 

  33. Nieto-Sampedro, M., Lewis, E.R., Cotman, C.W., et al. 1982. Brain injury causes a time-dependent increase in neurotrophic activity at the lesion site. Science 217:860–861.

    PubMed  Google Scholar 

  34. Graveland, G.A., Williams, R.S., and Difiglia, M. 1985. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Hungtington's disease. Science 227:770–773.

    PubMed  Google Scholar 

  35. Costa, E., and Guidotti, A. 1979. Molecular mechanism in the receptor action of benzodiazepines. Ann. Rev. Pharmacol. Toxicol. 19:531–545.

    Google Scholar 

  36. Costa, E., and Guidotti, A. 1987. Neuropeptides as cotransmitters: modulatory effects at GABAergic synapses. Pages 425–435.in Meltzer, H.Y. (ed). Psychopharmacology the third generation of progress. Raven Press, New York.

    Google Scholar 

  37. Branch, R.A., Morgan, M.H., James, J., and Read, A.E. 1976. Intravenous administration of diazepam in patients with chronic liver disease. Gut 17:975–983.

    PubMed  Google Scholar 

  38. Bakti, G., Fisch, H.U., Karlaganis, G., et al., 1987. Mechanism of the excessive sedative response of cirrhotics to benzodiazepine: model experiments with triazolam. Hepatology 7:629–638.

    PubMed  Google Scholar 

  39. Baraldi, M., Zeneroli, M.L., Ventura, E., et al. 1984. Supersensitivity of benzodiazepine receptor in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist. Clin. Sci. 67:167–175.

    PubMed  Google Scholar 

  40. Zeneroli, M.L., Baraldi, M., Pinelli, G., et al., 1985. Brain receptor changes in portal-systemic encephalopathy in dogs. Hepatology 5:953.

    Google Scholar 

  41. Biggio, G., Corda, M.G., Concas, A., and Gessa, G.L. 1981. Denervation supersensitivity for benzodiazepine receptors in rat substantia nigra. Brain Res. 220:344–349.

    PubMed  Google Scholar 

  42. Schafer, D.F., Fowler, J.M., Munson, P.J. et al. 1983. Gammaaminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure. J. Lab. Clin. Med. 102:870–880.

    PubMed  Google Scholar 

  43. Wysmyk-Cybula, U., Dabrowiexki, Z., and Albrecht, J. 1986. Changes in the metabolim and binding of GABA in the rat brain in thioacetamide-induced hepatogenic encephalopathy. Biomed. Biochim. Acta 3:413–419.

    Google Scholar 

  44. Maddison, J.E., Dodd, P.R., Johnston, J.A.R., and Farrell, G.C. 1987. Brain gamma-aminobutyric acid receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma gamma-aminobutyric acid-like activity. Gastroenterlogy 39:1062–1068.

    Google Scholar 

  45. Maddison, J.E., Dodd, P.R., Morrison, M. et al. 1987. Plasma GABA, GABA-like activity and the brain GABA-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy. Hepatology 7:621–628.

    PubMed  Google Scholar 

  46. Ferenci, P., Riederer, P. Jellinger, K., et al. 1988. Changes in cerebral receptors for gamma-aminobutyric acid in patients with hepatic encephalopathy. Liver 8:225–230.

    PubMed  Google Scholar 

  47. Butterworth, R.F., Lavoie, J., Giguere, J.F., and Pomier-Layrargues, G. 1988. Affinities and densities of high-affinity3H-muscimol (GABA-A) binding sites and of central benzodiazepine receptors are unchanged in autopsied brain tissues from cirrhotic patients with hepatic encephalopathy. Hepatology 8:1084–1088.

    PubMed  Google Scholar 

  48. Laidlaw, J., Read, A.E., and Sherlock, S. 1961. Morphine tolerance in hepatic cirrhosis. Gastroenterology 40:389–396.

    PubMed  Google Scholar 

  49. Ferenci, P., Pappas, S.C., Munson, P.J., Jones, A.E. 1984. Changes in glutamate receptors on synaptic membranes associated with hepatic encephalopathy or hyperammonemia in the rabbit. Hepatology 4:25–29.

    PubMed  Google Scholar 

  50. Butterworth, R.F., Lavoie, J., Szerb, J.C. et al. 1988. Excitatory amino acids in hepatic encephalopathy. Proceedings of International symposium on Hepatic encephalopathy: pathophysiology and treatment, Canada, Abs. 10.

  51. Moroni, F., Carla', V., Lombardi, G., et al. 1984. Excitatory aminoacids, trytophan metabolites and endogenous neurotoxins in porta-caval shunted rats. Pages 385–393,in Kleinberger, G., Ferenci, P., Rieder, P., Thaler, H. (eds), Advances in hepatic encephalopathy and urea cycle diseases, Karger, Basel.

    Google Scholar 

  52. Ukida, M., Morishita, H., Morimoto, Y. et al. 1988. Limited glutamine synthesis in brains of dogs with a portocaval anastomosis after 15N-ammonium chloride loading. Pages 433–438.in Soeters, P.B., Wilson, J.H.P., Meijer, A.J., and Holm, E. (eds). Advances in ammonia metabolism and hepatic encephalopathy, Excepta Medica, Amsterdam.

    Google Scholar 

  53. Rothman, S.M., and Olney, J.W. 1987. Excitotoxicity and the NMDA receptor. TINS 10:299–302.

    Google Scholar 

  54. Baraldi, M., Caselgrandi, E., Borella, P., et al. 1983. Zinc content in brain tissue and GABA receptor function in experimental hepatic encephalopathy. Pages 243–250.in Zbinden, C., Cuomo, V., Racagni, C., (eds), Application of behavioral pharmacology in toxicology, Raven Press, New York.

    Google Scholar 

  55. Baraldi, M., Zeneroli, M.L., Ricci, P., et al., 1983. Decrease of brain zinc in experimental hepatic encephalopathy. Brain Res. 258:170–172.

    Google Scholar 

  56. Baraldi, M., Pinelli, G., Ricci, P., and Zeneroli, M.L. 1984. Zinc in experimental hepatic encephalopathy. Pages 291–306.in Frederickson, C.J., Howel, G.A., and Kasarkis, E.J. (eds), The neurobiology of zine (part B), Alan R. Liss, New York.

    Google Scholar 

  57. Baraldi, M., Caselgrandi, E., and Santi, M. 1984. Effect of zinc on specific binding of GABA to rat brain membranes. Pages 59–71.in Frederickson, C.J., Howel, G.A., and Kasarkis, E.J. (eds), The neurobiology of zinc (part A), Alan R. Liss, New York.

    Google Scholar 

  58. Baraldi, M., Zanoli, P., Benelli, A., et al., 1986. Neurobehavioral, neuroendocrine and neurochemical effects of zinc supplementation in rats. Pages 571–585.in Schwarcz, R., and Ben-Ari, Y. (eds), Excitatory aminoacids and epilepsy, Plenum Press, New York.

    Google Scholar 

  59. Peters, S., Koh, J., and Choi, D.W. 1987. Zinc selectively blocks the action of n-methyl-d-aspartate on cortical neurons. Science 236:589–592.

    PubMed  Google Scholar 

  60. Westbrook, G.L., and Mayer, M.L. 1987. Micromolar concentrations of Zn antagonize NMDA and GABA responses of hippocampal neurons. Nature 328:640–643.

    PubMed  Google Scholar 

  61. Scollo-Lavizzari, G. 1985. Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788). Lancet 1:1324.

    Google Scholar 

  62. Bansky, G., Meier, P.I., Zeigler, W.H. et al. 1985. Reversal of hepatic encephalopathy by benzodiazepine antagonist (RO 15-1788). Lancet 1:1324–1325.

    Google Scholar 

  63. Sutherland, L.R., and Minuk, G.Y. 1988. RO 15-1788 and hepatic failure. Ann. Int. Md. 108:158.

    Google Scholar 

  64. Ferenci, P., Grimm, G., Meryn, S., and Gangl, A. 1989. Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil. Gastroenterology 96:240–243.

    PubMed  Google Scholar 

  65. Samsen, H., Bernau, J., Pappata, S. et al. 1987. Cerebral uptake of benzodiazepine measured by PET in hepatic encephalopathy. New Engl. J. Med. 316:414–415.

    PubMed  Google Scholar 

  66. Mullen, K.D., Martin J.V., Mendelson, W.B., et al. 1988. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy? Lancet 1:457–459.

    PubMed  Google Scholar 

  67. DeBlas, A.L. 1988. Diazepam and n-desmethyl-diazepam in plant food and in brain. TINS 11:489–490.

    PubMed  Google Scholar 

  68. Ferrero, P., Costa, E., Conti-Tronconi, B., and Guidotti, A. 1986. A diazepam-binding inhibitor (DBI)-like neuropeptide is detected in human brain. Brain Res. 399:136–142.

    PubMed  Google Scholar 

  69. Miyata, M., Mocchetti, I., Ferrarese, C., et al. 1987. Protracted treatment with diazepam increases the turnover of putative endogenos ligands for the benzodiazepine/beta-carboline recognition site. Proc. Natl. Acad. Sci. 84:1444–1448.

    PubMed  Google Scholar 

  70. Mullen, K.D., Szauter, K.M., Kaminsky, K., and Tolentino, P.D. 1988. Benzodiazepine-like activity is present in plasma of patients with hepatic encephalopathy at pharmacologically active concentrations. Hepatology 8:1254.

    Google Scholar 

  71. Olasmaa M., Guidotti, A., Costa, E., et al. 1989. Endogenous benzodiazepines in hepatic encephalopathy. Lancet 1:491–492.

    PubMed  Google Scholar 

  72. Robstein, J.D., Mckhann, G., Guarnieri, P., et al. Cerebrospinal fluid content of diazepam binding inhibitor (DBI) in chronic hepatic encephalopathy. Ann. Neurol. (in press).

  73. Zeneroli, M.L., Baraldi, M., Vezzelli, C., and Ventura, E. 1988. Neurochemical changes induced in brain of normal rats by the administration of ammonia, dimethyldisulfide and octanoic acid. Pages 252–258.in Soeters, P.B., Wilson, J.H.P., Meijer, A.J., and Holm, E. (eds). Advances in ammonia metabolism and hepatic encephalopathy, Excerpta Medica, Amsterdam.

    Google Scholar 

  74. Baraldi, M., Pinelli, G., Ricci, P., and Zeneroli, M.L. 1984. Toxins in hepatic encephalopathy: the role of the synergistic effect of ammonia, mercaptans and short chain fatty acids. Arch. Toxicol. 7:103–10.

    Google Scholar 

  75. Baradi, M., Zeneroli, M.L., Ventura, E., and Vezzelli, C. 1987. An increase in cerebral benzodiazepine receptors induced by a subacute administration of ammonia, mercaptans and short chain fatty acids in rats. Clin. Sci. 6:669–671.

    Google Scholar 

  76. Costa, E., Alho, H., Favaron, M., and Manev, H. 1989. Pharmacological implication of the allosteric modulation of neurotransmitter aminoacid receptors. Pages 3–18,in Barnard, E.A., Costa, E. Allosteric modulation of amino acid receptors: therapetic implications, Raven Press, New York.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Pharmacy, Department of Pharmaceutical Sciences, Modena University, 4110 Via S. Eufemia 19, Modena, Italy

    M. Baraldi (Chair of Pharmacology and Pharmacognosy)

Authors
  1. M. Baraldi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baraldi, M. Supersensitivity of GABA-A receptors in hepatic encephalopathy. Neurochem Res 15, 153–160 (1990). https://doi.org/10.1007/BF00972205

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00972205

Key Words

Search

Navigation